Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for chronic eosinophilic leukemia has been reported in the published literature.
9 clinical trials registered, 3 recruiting. Interventions under study include other interventions, drug therapy, gene therapy, and procedural interventions. Pipeline includes 2 PHASE2, 1 PHASE1. Research is primarily sponsored by academic and government institutions.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT01199562](https://clinicaltrials.gov/study/NCT01199562) |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 7:13 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about chronic eosinophilic leukemia
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant |
— |
City of Hope Medical Center |
ACTIVE_NOT_RECRUITING |
[NCT00898456](https://clinicaltrials.gov/study/NCT00898456) | Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia | — | Alliance for Clinical Trials in Oncology | UNKNOWN |
[NCT00544115](https://clinicaltrials.gov/study/NCT00544115) | Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders | PHASE2 | City of Hope Medical Center | ACTIVE_NOT_RECRUITING |
[NCT00935090](https://clinicaltrials.gov/study/NCT00935090) | 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer | — | Barbara Ann Karmanos Cancer Institute | ACTIVE_NOT_RECRUITING |
[NCT01137825](https://clinicaltrials.gov/study/NCT01137825) | Registry of Older Patients With Cancer | — | UNC Lineberger Comprehensive Cancer Center | RECRUITING |
33 publications have been identified in PubMed for chronic eosinophilic leukemia. Research spans Case Report / Case Series (58%), Review / Meta-Analysis (18%), and Diagnostic / Biomarker (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 58% |
Research summaries | 6 | 18% |
Testing and diagnosis research | 3 | 9% |
Laboratory research | 3 | 9% |
Clinical study results | 1 | 3% |
New treatment approaches | 1 | 3% |
Vallecillo-Viejo IC (2026). [PMID: 42253119](https://pubmed.ncbi.nlm.nih.gov/42253119/). *Br J Haematol*. [Gene Therapy / Novel Therapeutics]
Ji BC (2026). [PMID: 42005114](https://pubmed.ncbi.nlm.nih.gov/42005114/). *Cureus*. [Case Report / Case Series]
Chiang YK (2026). [PMID: 42014566](https://pubmed.ncbi.nlm.nih.gov/42014566/). *Pediatr Dermatol*. [Case Report / Case Series]
Krah NM (2026). [PMID: 42234946](https://pubmed.ncbi.nlm.nih.gov/42234946/). *JCO Precis Oncol*. [Basic Science / Preclinical]
Nardin M (2026). [PMID: 41738410](https://pubmed.ncbi.nlm.nih.gov/41738410/). *Giornale italiano di cardiologia (2006)*. [Case Report / Case Series]
Eletrebi MM (2026). [PMID: 42106910](https://pubmed.ncbi.nlm.nih.gov/42106910/). *Am J Clin Pathol*. [Diagnostic / Biomarker]
Rao NS (2026). [PMID: 42130655](https://pubmed.ncbi.nlm.nih.gov/42130655/). *Eur Heart J Case Rep*. [Case Report / Case Series]
Wu Y (2026). [PMID: 41689037](https://pubmed.ncbi.nlm.nih.gov/41689037/). *Journal of hematology & oncology*. [Case Report / Case Series]
Masood S (2025). [PMID: 40011991](https://pubmed.ncbi.nlm.nih.gov/40011991/). *Allergy and asthma proceedings*. [Review / Meta-Analysis]
Hwee J (2025). [PMID: 40486501](https://pubmed.ncbi.nlm.nih.gov/40486501/). *Frontiers in allergy*. [Clinical Trial Publication]